• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Will coronary artery bypass grafting remain a standard of care for elderly patients with multivessel disease in the contemporary era?

作者信息

Ono M, Onuma Y, Serruys P W, Wykrzykowska J J

机构信息

Department of Cardiology, Heart Center, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Department of Cardiology, National University of Ireland Galway, Galway, Ireland.

出版信息

Neth Heart J. 2020 Sep;28(9):457-459. doi: 10.1007/s12471-020-01477-z.

DOI:10.1007/s12471-020-01477-z
PMID:32737679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7431478/
Abstract
摘要

相似文献

1
Will coronary artery bypass grafting remain a standard of care for elderly patients with multivessel disease in the contemporary era?在当代，冠状动脉旁路移植术仍会是患有多支血管病变的老年患者的标准治疗方法吗？
Neth Heart J. 2020 Sep;28(9):457-459. doi: 10.1007/s12471-020-01477-z.
2
Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications.多支血管病变：用于经典冠状动脉旁路移植术适应症的经皮冠状动脉介入治疗
Angiology. 2008 Apr-May;59(2 Suppl):83S-8S. doi: 10.1177/0003319708318862. Epub 2008 Jun 10.
3
Robotic totally endoscopic multivessel coronary artery bypass grafting: procedure development, challenges, results.机器人全内镜多支冠状动脉旁路移植术：手术发展、挑战与结果
Innovations (Phila). 2012 Jan-Feb;7(1):3-8. doi: 10.1097/IMI.0b013e3182552ea8.
4
The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study：5 年随访：多血管病变糖尿病患者经皮冠状动脉介入治疗与冠状动脉旁路移植术血运重建的比较。
J Cardiovasc Med (Hagerstown). 2010 Jan;11(1):26-33. doi: 10.2459/JCM.0b013e328330ea32.
5
Long-term clinical outcome of coronary artery stenting or coronary artery bypass grafting in patients with multiple-vessel disease.多支血管病变患者冠状动脉支架置入术或冠状动脉旁路移植术的长期临床结局
J Thorac Cardiovasc Surg. 2008 Aug;136(2):500-6. doi: 10.1016/j.jtcvs.2007.11.050.
6
Fractional flow reserve-guided coronary artery bypass grafting: can intraoperative physiologic imaging guide decision making?分数血流储备指导下的冠状动脉旁路移植术：术中生理成像能指导决策吗？
J Thorac Cardiovasc Surg. 2013 Oct;146(4):824-835.e1. doi: 10.1016/j.jtcvs.2013.06.026. Epub 2013 Aug 1.
7
Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.冠状动脉旁路移植术与经皮冠状动脉介入治疗对多支血管病变患者长期死亡率和发病率的影响：动脉搭桥和支架时代随机临床试验的荟萃分析。
JAMA Intern Med. 2014 Feb 1;174(2):223-30. doi: 10.1001/jamainternmed.2013.12844.
8
Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.冠状动脉旁路移植术与药物洗脱支架置入术治疗左主干或多支冠状动脉疾病：一项个体患者数据的荟萃分析。
JACC Cardiovasc Interv. 2016 Dec 26;9(24):2481-2489. doi: 10.1016/j.jcin.2016.10.008.
9
Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials.药物洗脱支架经皮冠状动脉介入治疗与多支冠状动脉疾病患者冠状动脉旁路移植术的比较：六项随机对照试验的荟萃分析
Cardiovasc Revasc Med. 2015 Mar;16(2):70-7. doi: 10.1016/j.carrev.2015.01.002. Epub 2015 Jan 22.
10
Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group.阿根廷多支血管病变患者经皮腔内冠状动脉成形术与冠状动脉搭桥手术对比的随机试验（ERACI）：住院结果及1年随访。ERACI研究组
J Am Coll Cardiol. 1993 Oct;22(4):1060-7. doi: 10.1016/0735-1097(93)90416-x.

本文引用的文献

1
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.氯吡格雷与替格瑞洛或普拉格雷在 70 岁或以上非 ST 段抬高型急性冠脉综合征患者中的比较（POPular AGE）：随机、开放标签、非劣效性试验。
Lancet. 2020 Apr 25;395(10233):1374-1381. doi: 10.1016/S0140-6736(20)30325-1.
2
Long-term follow-up after bypass surgery or coronary stenting in elderly with multivessel disease.多支血管病变老年患者搭桥手术或冠状动脉支架置入术后的长期随访
Neth Heart J. 2020 Sep;28(9):467-477. doi: 10.1007/s12471-020-01415-z.
3
Initial Invasive or Conservative Strategy for Stable Coronary Disease.
稳定型冠心病的初始侵入性或保守治疗策略。
N Engl J Med. 2020 Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30.
4
Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.药物洗脱支架与冠状动脉旁路移植术治疗左主干病变的 10 年结果：PRECOMBAT 试验的扩展随访。
Circulation. 2020 May 5;141(18):1437-1446. doi: 10.1161/CIRCULATIONAHA.120.046039. Epub 2020 Mar 30.
5
Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干狭窄：NOBLE 随机非劣效性试验的 5 年更新结果。
Lancet. 2020 Jan 18;395(10219):191-199. doi: 10.1016/S0140-6736(19)32972-1. Epub 2019 Dec 23.
6
Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial.替格瑞洛单药治疗在 ACS 或老年稳定型 CAD 患者 PCI 后一个月以上：GLOBAL LEADERS 试验的预先指定分析。
EuroIntervention. 2020 Apr 3;15(18):e1605-e1614. doi: 10.4244/EIJ-D-19-00699.
7
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.左主干冠状动脉疾病经皮冠状动脉介入治疗或冠状动脉旁路移植术后 5 年的结果。
N Engl J Med. 2019 Nov 7;381(19):1820-1830. doi: 10.1056/NEJMoa1909406. Epub 2019 Sep 28.
8
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗三血管病变或左主干病变患者：多中心随机对照 SYNTAX 试验 10 年随访结果。
Lancet. 2019 Oct 12;394(10206):1325-1334. doi: 10.1016/S0140-6736(19)31997-X. Epub 2019 Sep 2.
9
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study.糖尿病患者多血管血运重建后的长期生存：FREEDOM 随访研究。
J Am Coll Cardiol. 2019 Feb 19;73(6):629-638. doi: 10.1016/j.jacc.2018.11.001. Epub 2018 Nov 11.
10
Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents.平衡药物洗脱支架经皮冠状动脉介入术后缺血和出血并发症的长期风险。
Am J Cardiol. 2015 Sep 1;116(5):686-93. doi: 10.1016/j.amjcard.2015.05.036. Epub 2015 Jun 3.